MSH3 Antibodies

Santa Cruz Biotechnology provides a broad selection of MSH3 monoclonal antibodies for research in DNA mismatch repair and genomic stability. MSH3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MSH3, or MutS Homolog 3, plays a critical role in the DNA repair process by recognizing and binding to mismatched DNA bases, thereby preventing mutations that could lead to cancer and other genetic disorders. Its function is essential for maintaining genomic integrity, and dysregulation of MSH3 has been implicated in various diseases, including colorectal cancer. Understanding MSH3 function in cellular processes is vital for advancing therapeutic strategies and improving patient outcomes. MSH3 research continues to reveal new insights into DNA repair mechanisms and their role in disease development. Ongoing studies of MSH3 are uncovering potential therapeutic targets for cancer treatment. Research utilizing MSH3 monoclonal antibodies has enhanced our understanding of genomic stability maintenance. Santa Cruz Biotechnology MSH3 monoclonal antibodies enable researchers worldwide to advance scientific knowledge in DNA repair and cancer biology.